AJAZ AFZAL: Open Payments
NPI 1750341236 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 13 payments from 11 companies in 2025. Trend: 2023 $654 · 2024 $359 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Braeburn Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| EVOKE PHARMA, INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: BREZTRI, XIFAXAN, BRIXADI, Symbravo, Quviviq, Wegovy, GIMOTI, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
